Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01661270

Completed

A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy (AFLAME)

Colorectal Cancer Metastatic
NCT01994291

Terminated

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

Macular Edema, Diabetic
NCT00644124

Completed

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Lymphoma, Non-Hodgkin
NCT00827554

Completed

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT01849692

Completed

ESBA1008 Microvolume Study

Exudative Age-Related Macular Degeneration
NCT01796964

Completed

Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Exudative Age-Related Macular Degeneration
NCT01405430

Completed

Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab (AVECC)

Colorectal Cancer | Metastasis
NCT01465230

Terminated

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
NCT00667277

Terminated

Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis

Myelofibrosis
NCT00109239

Completed

A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

Breast Cancer
NCT00109226

Completed

A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Colorectal Cancer
NCT01410370

Unknown

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Brain Metastases
NCT01831947

Completed

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. (RABIMO)

Macular Degeneration
NCT01714297

Completed

Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)

Infection | Arthritis of the Hip | Transfusion Related Complications | Wound Discharge
NCT00569699

Completed

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Colorectal Cancer
NCT00211432

Completed

Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Eye Diseases | Pseudovitellium Detachment
NCT01596738

Completed

Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation

Coronary Artery Disease | Coronary Artery Bypass Graft
NCT00726973

Withdrawn

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)

Macular Edema
NCT00031941

Completed

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific
NCT01260025

Completed

Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor

Pharmacokinetics | Tolerability | Endostatin
NCT00615147

Completed

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

Cancer | Pulmonary Embolism
NCT00039832

Completed

ReoPro and Retavase to Restore Brain Blood Flow After Stroke

Cerebrovascular Accident
NCT01072955

Unknown

Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Prevention of Venous Thromboembolism
NCT00120120

Completed

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Radiculopathy
NCT00211406

Terminated

Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Diabetic Retinopathy
NCT06904911

Recruiting

Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy (INTIMA-MT)

Acute Ischemic Stroke From Large Vessel Occlusion
NCT06461988

Recruiting

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Multiple Myeloma | Post Stem Cell Transplant
NCT06308406

Recruiting

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer
NCT06285019

Recruiting

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT05906524

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC
NCT05551208

Recruiting

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Ovarian Cancer
NCT05464394

Not yet recruiting

Peroperative Administration of Tranexamic Acid in Roux-en-Y Gastric Bypass and One-anastomosis Gastric Bypass (PATRY)

Hemorrhage | Bleeding
NCT05444088

Recruiting

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma
NCT05257213

Recruiting

Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy

Intrauterine Adhesion
NCT05102695

Not yet recruiting

Study of CRP, Ferritine and D-Dimer in Covid-19 Patients Admitted To Respiratory ICU in Assuit University Hospitals

Covid19
NCT05087199

Not yet recruiting

COVID-19 Infection in Patients With Chronic Pulmonary Diseases.

COVID-19 | Chronic Pulmonary Disease
NCT04918589

Not yet recruiting

Tranexamic Acid for Alloplastic Breast Reconstruction

Breast Cancer | Hematoma Postoperative | Tranexamic Acid
NCT04918576

Not yet recruiting

Topical Tranexamic Acid for Bilateral Breast Reduction Surgery

Hematoma Postoperative | Tranexamic Acid
NCT04682210

Not yet recruiting

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (DaDaLi)

HCC | Immunotherapy | Adjuvant Therapy
NCT05681884

Completed

Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)

Non-Proliferative Diabetic Retinopathy
NCT06116916

Active, not recruiting

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Diabetic Macular Edema (DME)
NCT05930561

Active, not recruiting

4D-150 in Patients With Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema
NCT06991530

Completed

Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure

IVF | Recurrent Implantation Failure | FET | Low Molecular Weight Heparin
NCT03227263

Completed

BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). (BABH)

Telangiectasia, Hereditary Hemorrhagic | Rendu Osler Disease
NCT06022068

Completed

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (ERAP)

Alzheimer Disease
NCT05788289

Terminated

A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Mantle Cell Lymphoma | MCL
NCT06134622

Completed

Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT) (ASSET-IT)

Acute Ischemic Stroke
NCT06232902

Completed

A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers

Tumor
NCT04036448

Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea (RevlimidPMS)

Lymphoma, Follicular | Myelodysplastic Syndromes | Lymphoma, Mantle-Cell
NCT05704725

Completed

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

Chorioretinal Vascular Disease

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations